Marla C. Dubinsky, MD

Susan and Leonard Feinstein IBD Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Poster(s):

• P3231 - Mirikizumab Demonstrates Rapid and Sustained Improvements in Bowel Urgency Measures and Clinical Measures in Moderately-to-Severely Active Ulcerative Colitis: 28-Week Results from the Phase 3b LUCENT-URGE Trial
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT

• P3232 - Prevalence and Factors Associated With Optimal Disease Control in Crohn’s Disease and Ulcerative Colitis: Views on Inflammatory Bowel Disease Expectations and Well-Being by Patients and Treatment Providers
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT